1966 related articles for article (PubMed ID: 32074550)
21. Discovering drugs to treat coronavirus disease 2019 (COVID-19).
Dong L; Hu S; Gao J
Drug Discov Ther; 2020; 14(1):58-60. PubMed ID: 32147628
[TBL] [Abstract][Full Text] [Related]
22. Improving the efficacy of Chloroquine and Hydroxychloroquine against SARS-CoV-2 may require Zinc additives - A better synergy for future COVID-19 clinical trials.
Shittu MO; Afolami OI
Infez Med; 2020 Ahead of print Jun 1; 28(2):192-197. PubMed ID: 32335560
[TBL] [Abstract][Full Text] [Related]
23. Chloroquine in COVID-19: the evidence.
Gupta N; Agrawal S; Ish P
Monaldi Arch Chest Dis; 2020 Mar; 90(1):. PubMed ID: 32231349
[TBL] [Abstract][Full Text] [Related]
24. Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine.
Sahraei Z; Shabani M; Shokouhi S; Saffaei A
Int J Antimicrob Agents; 2020 Apr; 55(4):105945. PubMed ID: 32194152
[No Abstract] [Full Text] [Related]
25. Chloroquine and hydroxychloroquine in covid-19.
Ferner RE; Aronson JK
BMJ; 2020 Apr; 369():m1432. PubMed ID: 32269046
[No Abstract] [Full Text] [Related]
26. Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19).
Gao J; Hu S
Biosci Trends; 2020 May; 14(2):156-158. PubMed ID: 32281583
[TBL] [Abstract][Full Text] [Related]
27. Chloroquine and hydroxychloroquine for the prevention and therapy of coronavirus disease 2019: new hopes and old cardiovascular concerns.
Jankowska EA; Sierpiński R; Tkaczyszyn M; Drozd M; Szachniewicz J; Duda-Sikuła M; Knysz B; Simon K; Szenborn L; Ponikowski P
Kardiol Pol; 2020 Aug; 78(7-8):811-817. PubMed ID: 32687267
[No Abstract] [Full Text] [Related]
28. Advances and challenges in the prevention and treatment of COVID-19.
Han YJ; Ren ZG; Li XX; Yan JL; Ma CY; Wu DD; Ji XY
Int J Med Sci; 2020; 17(12):1803-1810. PubMed ID: 32714083
[TBL] [Abstract][Full Text] [Related]
29. [Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus].
Zhang YS; Cong WH; Zhang JJ; Guo FF; Li HM
Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1263-1271. PubMed ID: 32281335
[TBL] [Abstract][Full Text] [Related]
30. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.
de Barros CM; Almeida CAF; Pereira B; Costa KCM; Pinheiro FA; Maia LDB; Trindade CM; Garcia RCT; Torres LH; Diwan S; Boralli VB
Pain Physician; 2020 Aug; 23(4S):S351-S366. PubMed ID: 32942793
[TBL] [Abstract][Full Text] [Related]
31. Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19.
Gevers S; Kwa MSG; Wijnans E; van Nieuwkoop C
Clin Microbiol Infect; 2020 Sep; 26(9):1276-1277. PubMed ID: 32422406
[No Abstract] [Full Text] [Related]
32. Use of chloroquine or hydroxychloroquine in treatment of COVID-19: is it ethical?
Allam MF; Andraous F
Cent Eur J Public Health; 2020 Sep; 28(3):246-247. PubMed ID: 32997483
[No Abstract] [Full Text] [Related]
33. Mass intake of hydroxychloroquine or chloroquine in the present context of the Covid-19 outbreak: Possible consequences in endemic malaria settings.
Mvumbi DM
Med Hypotheses; 2020 Oct; 143():109912. PubMed ID: 32498009
[No Abstract] [Full Text] [Related]
34. Do we have enough evidence to use chloroquine/hydroxychloroquine as a public health panacea for COVID-19?
Palmeira VA; Costa LB; Perez LG; Ribeiro VT; Lanza K; Silva ACSE
Clinics (Sao Paulo); 2020; 75():e1928. PubMed ID: 32401962
[No Abstract] [Full Text] [Related]
35. Emerging prophylaxis strategies against COVID-19.
Agrawal S; Goel AD; Gupta N
Monaldi Arch Chest Dis; 2020 Mar; 90(1):. PubMed ID: 32231348
[TBL] [Abstract][Full Text] [Related]
36. Antiviral therapy for coronavirus disease 2019.
Gong S; Su J; Yan X; Li F; Hu L; Liu S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):598-602. PubMed ID: 32879113
[TBL] [Abstract][Full Text] [Related]
37. [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
Plaze M; Attali D; Petit AC; Blatzer M; Simon-Loriere E; Vinckier F; Cachia A; Chrétien F; Gaillard R
Encephale; 2020 Jun; 46(3S):S35-S39. PubMed ID: 32387014
[TBL] [Abstract][Full Text] [Related]
38. Drug Evaluation during the Covid-19 Pandemic.
Rome BN; Avorn J
N Engl J Med; 2020 Jun; 382(24):2282-2284. PubMed ID: 32289216
[No Abstract] [Full Text] [Related]
39. The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?
Quiros Roldan E; Biasiotto G; Magro P; Zanella I
Pharmacol Res; 2020 Aug; 158():104904. PubMed ID: 32430286
[TBL] [Abstract][Full Text] [Related]
40. Teicoplanin: an alternative drug for the treatment of COVID-19?
Baron SA; Devaux C; Colson P; Raoult D; Rolain JM
Int J Antimicrob Agents; 2020 Apr; 55(4):105944. PubMed ID: 32179150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
